CONGRESS | #cGvHD2026 | ORAL PRESENTATION
Maria Helena Parrinello presents data from a study aiming to validate the #cGvHD immune reconstitution (IR) score in a contemporary cohort of patients (N = 166), and evaluate its utility in predicting 5-year outcomes including cGvHD-free survival and relapse (historical cohort, n = 127; contemporary cohort, n = 78).
The IR score offers a practical, clinically applicable tool for long-term allo-HSCT survivors, stratifying 3-year OS from cGvHD onset. Low-risk scores are strongly associated with IST discontinuation at 5 years.
Follow our live feed for more updates: https://t.co/Z8MqTc6beZ
Intended for HCPs only. This congress coverage is independently supported by pharmaceutical companies, who are allowed no influence on the content; a full list of supporters can be found on our website.
#GvHD #GvHDsm #MedNews #MedEd
1 day to go!
The GvHD Hub is excited to cover the 52nd Annual Meeting of the EBMT.
📅 March 22–25, 2026
📍 Madrid, ES and online
Keep an eye on our social channels for live coverage.
#EBMT26@TheEBMT
CONGRESS | #IACH | PRESENTATION
Maria Helena Parrinello @Emmeaccapi, San Raffaele Hospital, presents a case study of a patient with cGvHD and new-onset dysphagia. Parrinello highlights the importance of long-term monitoring for detection of secondary malignancies after HSCT.
Follow our live feed for more updates: https://t.co/vNwqmO0Rzb
Intended for HCPs only. This congress coverage is independently supported by pharmaceutical companies, who are allowed no influence on the content. A full list of supporters can be found on our website.
#GvHD #GvHDsm #MedicalCongress